Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

August 29, 2024

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer Dr. Bermudes Widely Considered...

August 6, 2024

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024 Recorded Positive Quarterly Net Income...

July 23, 2024

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

BURLINGTON, Mass. and JERUSALEM, Israel, July 23, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

June 17, 2024

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 10, 2024

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Shortened Acute Treatment Period Could Enhance Appeal and Market Opportunities of Deep TMS™ BURLINGTON,...

June 3, 2024

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between...

May 8, 2024

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income...

April 24, 2024

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

April 17, 2024

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates Company...

April 4, 2024

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson’s Disease

Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms JERUSALEM...

March 28, 2024

BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis

Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON,...

March 18, 2024

BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems

Katie’s Way Provides Lifesaving Mental Health Treatment Nationally with a Focus on Servicemembers,...

March 6, 2024

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive...

February 21, 2024

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

BURLINGTON, Mass. and JERUSALEM, Israel, February 21, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

January 10, 2024

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

December 19, 2023

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

December 7, 2023

BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea

BURLINGTON, Mass. and JERUSALEM, December X, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

November 20, 2023

Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives

BURLINGTON, Mass. and JERUSALEM, November 20, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

Find a provider near you or contact us today.

Find a Provider Contact Us